Literature DB >> 22325616

The global burden of neglected tropical diseases.

A Fenwick1.   

Abstract

The first comprehensive study on the global burden of disease and risk factors was commissioned by the World Bank in 1992. A follow-up study was performed in 2005, and another iteration was commissioned by the World Health Organization in 2010, due for publication in 2011. The author suggests that the global burden of neglected tropical diseases (NTDs) has been seriously underestimated. The way forward is the integration of control efforts, with programmes coming together to deliver a package of drugs against NTDs. Barriers to continent-wide coverage of drugs against NTDs are political will (missing in those countries with poor governance), funding (approximately half of the $1.5-2 billion is needed) and human resources. However, if the donors who give so much to malaria, tuberculosis and human immunodeficiency virus would share just 10% of the amount allocated to the big three, the most common NTDs could become diseases of the past. This could well happen within 7 years, and the targets of GET2020 (Global Elimination of Trachoma by 2020) to eliminate trachoma and GAELF (the Global Alliance to Eliminate Lymphatic Filariasis) to eliminate lymphatic filariasis by 2020 are achievable. Copyright Â
© 2011 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325616     DOI: 10.1016/j.puhe.2011.11.015

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  63 in total

1.  Disease ecology, health and the environment: a framework to account for ecological and socio-economic drivers in the control of neglected tropical diseases.

Authors:  A Garchitorena; S H Sokolow; B Roche; C N Ngonghala; M Jocque; A Lund; M Barry; E A Mordecai; G C Daily; J H Jones; J R Andrews; E Bendavid; S P Luby; A D LaBeaud; K Seetah; J F Guégan; M H Bonds; G A De Leo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-06-05       Impact factor: 6.237

2.  Neglected tropical diseases and vitamin B12: a review of the current evidence.

Authors:  Alexander J Layden; Kristos Täse; Julia L Finkelstein
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-10-01       Impact factor: 2.184

Review 3.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.

Authors:  Martial L Ndeffo Mbah; Jennifer A Gilbert; Alison P Galvani
Journal:  Epidemics       Date:  2014-04-29       Impact factor: 4.396

Review 5.  Susceptibility or resistance of praziquantel in human schistosomiasis: a review.

Authors:  Wei Wang; Li Wang; You-Sheng Liang
Journal:  Parasitol Res       Date:  2012-10-07       Impact factor: 2.289

Review 6.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

7.  Autofocusing MALDI mass spectrometry imaging of tissue sections and 3D chemical topography of nonflat surfaces.

Authors:  Mario Kompauer; Sven Heiles; Bernhard Spengler
Journal:  Nat Methods       Date:  2017-09-18       Impact factor: 28.547

8.  Ion channels and drug transporters as targets for anthelmintics.

Authors:  Robert M Greenberg
Journal:  Curr Clin Microbiol Rep       Date:  2014-12

9.  Prevalence and distribution of Schistosoma haematobium infection among school children living in southwestern shores of Lake Malawi.

Authors:  Sekeleghe Kayuni; Rosanna Peeling; Peter Makaula
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

Review 10.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.